Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Test Finds Hypoxia and Alzheimer's Pathway Link

May 12, 2011 7:19 am | News | Comments

Quanterix announced significant elevations in blood levels of amyloid beta (Abeta) 42 peptide, a hallmark of Alzheimer’s disease, were detected using the company’s the Single Molecule Array (SiMoA)  technology in patients who experienced hypoxia following cardiac arrest.

TOPICS:

Organic Catalyst Could Lower Costs, Toxicity

May 12, 2011 5:35 am | News | Comments

A new organocatalyst developed at Oregon State University (OSU) could make new drug development around the world less costly, more efficient and more environmentally friendly, the developers say.

TOPICS:

Blood Pressure Drug Shows Some Muscle

May 12, 2011 5:25 am | News | Comments

Using geriatric mice, researchers have shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

TOPICS:
Advertisement

Only 44% of Patients Always Take Meds

May 11, 2011 11:51 am | News | Comments

Disease-modifying drugs slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But a new study found low adherence to all DMDs, with less than half of patients continually adherent after two years.

TOPICS:

J & J Upgraded to Buy, BMS Outlook Down

May 11, 2011 11:45 am | News | Comments

A Goldman Sachs analyst said that investors are overlooking Johnson & Johnson's product pipeline, upgrading the stock to "Buy" while downgrading shares of Bristol-Myers Squibb Co. to "Neutral."

TOPICS:

American Bioanalytical Earns ISO 13485 Certication

May 11, 2011 11:43 am | News | Comments

American Bioanalytical Inc. has received ISO 13485:2003 Certification, an internationally recognized quality standard designed to ensure that medical device manufacturers have required quality management systems.

TOPICS:

Former Biogen Idec VP Moves to Patheon

May 11, 2011 11:33 am | News | Comments

Patheon announced the appointment of Michael E. Lytton as Patheon’s Executive Vice President, Corporate Development and Strategy and General Counsel, effective immediately.

TOPICS:

Sulfhydryl Coupling Resin

May 11, 2011 11:30 am | Product Releases | Comments

G-Biosciences presents Sulfhydryl Coupling Resin which is designed for the simple and efficient coupling of peptides and proteins. Utilizing free sulfhydryl groups, a 6% agarose support is used in conjunction with covalent thioether bonds for stable coupling.

TOPICS:
Advertisement

Solid Phase Extraction

May 11, 2011 11:26 am | Product Releases | Comments

To meet the demands of the analytical world, Horizon Technology developed the Fast Flow Sediment Disk Holder. The Fast Flow Sediment Disk Holder allows laboratories to use an economical 47 mm SPE disk while still maintaining the use of a 100 mm prefilter.

TOPICS:

Cytheris Opening Clinical Trial for CYT107

May 11, 2011 11:15 am | News | Comments

Cytheris SA, the Centre Léon Bérard, and ImmunID Technologies SAS initiated a Phase 2a clinical trial that will evaluate multiple combinations of recombinant human interleukin-7 (CYT107) and XELODA in the treatment of metastatic breast cancer.

TOPICS:

FDA And EMA Receive Vemurafenib Applications

May 11, 2011 11:04 am | News | Comments

Genentech has submitted a New Drug Application for vemurafenib to the U.S. Food and Drug Administration for BRAF V600 mutation-positive metastatic melanoma, and that Roche submitted a Marketing Authorization Application to the European Medicines Agency for the same indication.

TOPICS:

Boston Scientific Takes Home $19.5M in Stent Case

May 11, 2011 11:00 am | News | Comments

Boston Scientific Corp. said that a federal jury awarded it $19.5 million in a dispute with rival Johnson & Johnson over stents. A jury found that J&J's Cordis unit owed Boston Scientific for infringing its Jang patent.

TOPICS:

SciClone Bottom Line Stung by Bribery Scandal

May 11, 2011 10:57 am | News | Comments

SciClone Pharmaceuticals Inc. said that its first-quarter profit fell 8% on higher costs related to a government investigation alleging bribery to foreign officials in order to secure business overseas.

TOPICS:

FDA Approves First Microneedle Vaccine

May 11, 2011 10:55 am | by Linda A. Johnson | News | Comments

The Food and Drug Administration has approved the first flu shot injected with a tiny needle into skin cells rather than muscle. Sanofi Pasteur said that regulators approved the Fluzone Intradermal vaccine for adults 18 through 64 years old.

TOPICS:

Teva Profits Hit $761M

May 11, 2011 10:50 am | News | Comments

Teva Pharmaceutical Industries Ltd. said its profit rose 7 percent in the first quarter as its latest acquisitions boosted its sales overseas. The world's largest maker of generic drugs said its profit grew to $761 million.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading